Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupComplicationsDiseaseExtravasation, Anthracycline (complication)SubgroupICD10T80.-MeSHAnthracyclinesSequenceAntineoplastic therapySubstanceSubstanceSubstanceSubstanceNo. Substances RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionDexrazoxaneSubstanceBalanced Crystalloid SolutionDexrazoxaneSubstanceBalanced Crystalloid SolutionDexrazoxaneSubstanceBalanced Crystalloid SolutionDexrazoxaneNo. Substances2Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseSalvageTherapy intentionsupportiveRisksDiarrheaEmetogenicityFatigueInfectionsPyrexia only studiesPublicationAuthorMouridsen HDiseaseExtravasation nach Anthrazyklin, ECOG 0-2OriginDepartment of Oncology, Copenhagen University Hospital, DenmarkProtocols in Revision 1 protocol foundDexrazoxane 1000 / 500, anthracycline extravasation (PID59 V1.1)
